Recent Comments

Comment RSS

H5N1 News and Research RSS Feed - H5N1 News and Research Twitter

Influenza A (H5N1) virus – also called “H5N1 virus” – is an influenza A virus subtype that occurs mainly in birds, is highly contagious among birds, and can be deadly to them. H5N1 virus does not usually infect people, but infections with these viruses have occurred in humans. Most of these cases have resulted from people having direct or close contact with H5N1-infected poultry or H5N1-contaminated surfaces.

Inovio Biomedical announces positive test results of its consensus influenza vaccines

20. November 2009 06:39
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. [More]

DxNA announces successfull evaluation of its GeneSTAT PCR system

19. November 2009 07:45
DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture. [More]

Posted in: Device / Technology News | Medical Science News

Tags: , , , ,

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

19. November 2009 06:05
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission. [More]

Posted in: Business / Finance

Tags: , , , ,

Why avian flu virus has not caused a pandemic?

19. November 2009 05:01
Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

18. November 2009 11:14
CEL-SCI Corporation, a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine (Johns Hopkins). [More]

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

18. November 2009 07:17
Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine. The population has been expanded to include people over 60 years old. The shelf life for PANFLU.1 was extended to one year from six months. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , , ,

Asuragen enters into an exclusive agreement with Life Technologies

18. November 2009 04:13
Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). [More]

Posted in: Business / Finance | Device / Technology News

Tags: , , , , , , ,

Special report on past influenza pandemics and recent virus scares

17. November 2009 05:18
Research and Markets (http://www.researchandmarkets.com/research/5ec1bd/special_report_th) has announced the addition of Decision Resources, Inc.'s new report "Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009" to their offering. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , , , ,

New Web-based application for tracking the H1N1 flu virus across the globe

17. November 2009 02:58
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say. [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: , , , , , ,

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

16. November 2009 06:42
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009. [More]

Positive results from Puricore's Vashe Wound Therapy efficacy trial

11. November 2009 07:48
PuriCore, the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, today announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries. [More]

NanoViricides to present data on its in vivo studies against influenza

9. November 2009 08:14
NanoViricides, Inc., announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment. [More]

Posted in: Medical Research News | Disease/Infection News

Tags: , , , , , , , ,

Puricore reports increase in sales of 25% in Q3

3. November 2009 08:03
PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today issues an Interim Management Statement covering the three-month and nine-month periods ending September 30, 2009. [More]

Posted in: Business / Finance

Tags: , , , , , ,

sanofi-aventis reports financial results for the third quarter of 2009

30. October 2009 08:59
In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies. [More]

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

28. October 2009 01:53
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.